Citation: 杨春明. Diagnosis and Treatment of Common Pancreatic Neuroendocrine Tumors. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(10): 1029-1032. doi: Copy
1. | Heller MT, Shah AT. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548. |
2. | Eriksson B, Oberg K. Neuroendocrine tumors of the pancreas[J]. Br J Surg, 2000, 87(2):129-131. |
3. | Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification[J]. Ann NY Acad Sci, 2004, 1014(1):13-27. |
4. | Kulke MH, Anthony LB, Bushe11 DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752. |
5. | Yao JC, Hassan M, Phan A, et al. One hundred years after“carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States[J]. J Clin Oncol, 2008, 26(18):3063-3072. |
6. | Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1): 1-18. |
7. | Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic)[J]. Neuroendocrinology, 2006, 84(1):173-182. |
8. | Kloppel G, Anlauf M. Gartrinoma-morphological aspects[J]. Wein Klin Wocherschr, 2007, 119(5):574-584. |
9. | Vanderveen K, Grant C. Insulinoma[J]. Cancer Treat Res, 2010, 153(2):235-252. |
10. | Jensen RT, Cadiot G, Brandi ML. ENETs consensus guidelines for the management of patients with digestive neuroendocrineneoplasms:functional pancreatic endocrine tumor syndromes[J]. Neuroendocrinology, 2012, 95(1):98-119. |
11. | Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology[J]. Arch Pathol Lab Med, 2008, 132(8):1285-1289. |
12. | Bosman FT. WHO Classification of Tumors of the DigestiveSystem[M]. Lyon , IARC Press, 2010. |
13. | De Herder WW, Niederle B, Scoazes JY, et al. Well-differentiated pancreatic tumor/carcinoma:insulinoma[J]. Neuroendoocrinology, 2006, 84(1):183-188. |
14. | Vinik AI, Gonzales MRC. New and emerging syndromes due to neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1):19-63. |
15. | Osefo N, Ito T, Jensen RT. Gastric acid hypersecetory states:recent insights and advances[J]. Curr Gastroenterol Rep, 2009, 11(4):433-441. |
16. | Metz DG, Jensen RT. Gastrointestinal neuroendocrine tumors:pancreatic endocrine tumors[J]. Gastroenterology, 2008, 135(5):1469-1492. |
17. | Heller MT, Shah AB. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548. |
18. | Morrow EH, Norton JA. Surgical management of Zollinger-Ellison syndrome; state of the art[J]. Surg Clin North Am, 2009, 89(5):1091-1103. |
19. | Ruf J, Heuck F, Schiefer J, et al. Impact of multiple 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors[J]. Neuendocrinology, 2010, 91(1):101-109. |
20. | Sundin A, Garake U, Orlefors H. Nuclear imaging of neurooendocrine tumors[J]. Best Pract Res Clin Endocrinal Metab, 2007, 21(1):69-85. |
21. | Norton JA, Jeusen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellisonsyndrome[J]. Ann Surg , 2004, 240(5):757-773. |
22. | Gouolet P, Muret A, Bingut C, et al. Risk factors and causes of death in MEN-1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients[J]. World J Surg, 2010, 34(2):249-255. |
23. | Figueiredo FA, Giovannini M, Monges G, et al. Pancreaticendocrine tumors:a large single center experience[J]. Pancrease, 2009, 38(8):936-940. |
24. | Boudrcause JP. Surgery for gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1):163-171. |
25. | Woltering E, Cundiff, Lyous J. Neuroendocrine tumors of the gastroenteropancreatic axis//Silberman H, Silberman AW. ed. Principles and Practice of Surgical Oncology[M]. Philadephia:Lippincott Williams & Wilkins, 2010:769-800. |
26. | Lorenz K, Dralle H. Surgical treatment of sporadic gastrinoma[J]. Wien Klin Wochenschr, 2007, 119(19-20):597-601. |
27. | Grobmyer SR, Vogel SB, McGuigan JE, et al. Reoperativesurgery in sporadic Zollinger-Ellison Syndrome:long-term results[J]. J Am Coll Surg, 2009, 208(6):718-722. |
28. | Fendrich V, Langer P, Waldmann J, et al. Management ofsporadic and multiple endocrine neoplasia type 1 gastrinomas[J]. Br J Surg, 2007, 94(11):1331-1341. |
29. | Fernandaz-Cruz L, Blanco L, Cosa R, et al. Is laparoscopic resection adequate in patients with neoroendocrine pancreatictumors[J]. World J Surg, 2008, 32(5):904-917. |
30. | Isla A, Arbuckle JD, Kekis PB, et al. Laparoscopic management of insulinoma[J]. Br J Srug, 2009, 96(2):185-190. |
31. | Gimm V, König E, Thanh PN, et al. Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI)[J]. Langenbecks Arch Surg, 2007, 392(6):679-684. |
32. | Akerstron G, Hellman P. Surgery on neuroendocrine tumors[J]. Best Pract Res Clin Endocrinol Metab, 2007, 21(1):87-109. |
33. | Joseph S, Wang YZ, Boudreaux JP, et al. Neuroendocrinetumors: current recommendations for diagnosis and surgical management[J]. Endocrinol Metab Clin North Am, 2011, 40(1):205-231. |
- 1. Heller MT, Shah AT. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548.
- 2. Eriksson B, Oberg K. Neuroendocrine tumors of the pancreas[J]. Br J Surg, 2000, 87(2):129-131.
- 3. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification[J]. Ann NY Acad Sci, 2004, 1014(1):13-27.
- 4. Kulke MH, Anthony LB, Bushe11 DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752.
- 5. Yao JC, Hassan M, Phan A, et al. One hundred years after“carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States[J]. J Clin Oncol, 2008, 26(18):3063-3072.
- 6. Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1): 1-18.
- 7. Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic)[J]. Neuroendocrinology, 2006, 84(1):173-182.
- 8. Kloppel G, Anlauf M. Gartrinoma-morphological aspects[J]. Wein Klin Wocherschr, 2007, 119(5):574-584.
- 9. Vanderveen K, Grant C. Insulinoma[J]. Cancer Treat Res, 2010, 153(2):235-252.
- 10. Jensen RT, Cadiot G, Brandi ML. ENETs consensus guidelines for the management of patients with digestive neuroendocrineneoplasms:functional pancreatic endocrine tumor syndromes[J]. Neuroendocrinology, 2012, 95(1):98-119.
- 11. Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology[J]. Arch Pathol Lab Med, 2008, 132(8):1285-1289.
- 12. Bosman FT. WHO Classification of Tumors of the DigestiveSystem[M]. Lyon , IARC Press, 2010.
- 13. De Herder WW, Niederle B, Scoazes JY, et al. Well-differentiated pancreatic tumor/carcinoma:insulinoma[J]. Neuroendoocrinology, 2006, 84(1):183-188.
- 14. Vinik AI, Gonzales MRC. New and emerging syndromes due to neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1):19-63.
- 15. Osefo N, Ito T, Jensen RT. Gastric acid hypersecetory states:recent insights and advances[J]. Curr Gastroenterol Rep, 2009, 11(4):433-441.
- 16. Metz DG, Jensen RT. Gastrointestinal neuroendocrine tumors:pancreatic endocrine tumors[J]. Gastroenterology, 2008, 135(5):1469-1492.
- 17. Heller MT, Shah AB. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548.
- 18. Morrow EH, Norton JA. Surgical management of Zollinger-Ellison syndrome; state of the art[J]. Surg Clin North Am, 2009, 89(5):1091-1103.
- 19. Ruf J, Heuck F, Schiefer J, et al. Impact of multiple 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors[J]. Neuendocrinology, 2010, 91(1):101-109.
- 20. Sundin A, Garake U, Orlefors H. Nuclear imaging of neurooendocrine tumors[J]. Best Pract Res Clin Endocrinal Metab, 2007, 21(1):69-85.
- 21. Norton JA, Jeusen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellisonsyndrome[J]. Ann Surg , 2004, 240(5):757-773.
- 22. Gouolet P, Muret A, Bingut C, et al. Risk factors and causes of death in MEN-1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients[J]. World J Surg, 2010, 34(2):249-255.
- 23. Figueiredo FA, Giovannini M, Monges G, et al. Pancreaticendocrine tumors:a large single center experience[J]. Pancrease, 2009, 38(8):936-940.
- 24. Boudrcause JP. Surgery for gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1):163-171.
- 25. Woltering E, Cundiff, Lyous J. Neuroendocrine tumors of the gastroenteropancreatic axis//Silberman H, Silberman AW. ed. Principles and Practice of Surgical Oncology[M]. Philadephia:Lippincott Williams & Wilkins, 2010:769-800.
- 26. Lorenz K, Dralle H. Surgical treatment of sporadic gastrinoma[J]. Wien Klin Wochenschr, 2007, 119(19-20):597-601.
- 27. Grobmyer SR, Vogel SB, McGuigan JE, et al. Reoperativesurgery in sporadic Zollinger-Ellison Syndrome:long-term results[J]. J Am Coll Surg, 2009, 208(6):718-722.
- 28. Fendrich V, Langer P, Waldmann J, et al. Management ofsporadic and multiple endocrine neoplasia type 1 gastrinomas[J]. Br J Surg, 2007, 94(11):1331-1341.
- 29. Fernandaz-Cruz L, Blanco L, Cosa R, et al. Is laparoscopic resection adequate in patients with neoroendocrine pancreatictumors[J]. World J Surg, 2008, 32(5):904-917.
- 30. Isla A, Arbuckle JD, Kekis PB, et al. Laparoscopic management of insulinoma[J]. Br J Srug, 2009, 96(2):185-190.
- 31. Gimm V, König E, Thanh PN, et al. Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI)[J]. Langenbecks Arch Surg, 2007, 392(6):679-684.
- 32. Akerstron G, Hellman P. Surgery on neuroendocrine tumors[J]. Best Pract Res Clin Endocrinol Metab, 2007, 21(1):87-109.
- 33. Joseph S, Wang YZ, Boudreaux JP, et al. Neuroendocrinetumors: current recommendations for diagnosis and surgical management[J]. Endocrinol Metab Clin North Am, 2011, 40(1):205-231.